BR9707261A - Compound processes for preparing them and pharmaceutical products and compositions - Google Patents
Compound processes for preparing them and pharmaceutical products and compositionsInfo
- Publication number
- BR9707261A BR9707261A BR9707261A BR9707261A BR9707261A BR 9707261 A BR9707261 A BR 9707261A BR 9707261 A BR9707261 A BR 9707261A BR 9707261 A BR9707261 A BR 9707261A BR 9707261 A BR9707261 A BR 9707261A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- preparing
- pharmaceutical products
- compound processes
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9601275A FR2744448B1 (en) | 1996-02-02 | 1996-02-02 | NOVEL PIPERIDINES DERIVED FROM ARYL PIPERAZINE, AS WELL AS THEIR PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS MEDICAMENTS |
PCT/FR1997/000195 WO1997028140A1 (en) | 1996-02-02 | 1997-01-31 | NOVEL PIPERIDINES DERIVED FROM 1-/(PIPERAZIN-1-YL)ARYL(OXY/AMINO)CARBONYL/-4-ARYL-PIPERIDINE AS SELECTIVE 5-HT1Db RECEPTOR ANTAGONISTS |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9707261A true BR9707261A (en) | 1999-07-20 |
Family
ID=9488770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9707261A BR9707261A (en) | 1996-02-02 | 1997-01-31 | Compound processes for preparing them and pharmaceutical products and compositions |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0886636A1 (en) |
JP (1) | JP2000504004A (en) |
CN (1) | CN1212690A (en) |
AU (1) | AU1607097A (en) |
BR (1) | BR9707261A (en) |
CA (1) | CA2244940A1 (en) |
FR (1) | FR2744448B1 (en) |
MX (1) | MX9806246A (en) |
NZ (1) | NZ331221A (en) |
WO (1) | WO1997028140A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2758327B1 (en) * | 1997-01-15 | 1999-04-02 | Pf Medicament | NEW ARYLPIPERAZINES DERIVED FROM PIPERIDINE |
CN1608050A (en) * | 2001-12-21 | 2005-04-20 | 大正制药株式会社 | Piperazine derivative |
UA77536C2 (en) | 2002-07-03 | 2006-12-15 | Lundbeck & Co As H | Secondary aminoaniline piperidines as mch1 antagonists and their use |
CN1829708A (en) * | 2003-07-24 | 2006-09-06 | 尤罗塞尔蒂克股份有限公司 | Piperidine compounds and pharmaceutical compositions containing them |
JP4521777B2 (en) * | 2003-07-24 | 2010-08-11 | ユーロ−セルティーク エス.エイ. | 4-Heteroaryl-tetrahydropiperidyl compounds useful for the treatment or prevention of pain |
EP1867644B1 (en) | 2003-07-24 | 2009-05-20 | Euro-Celtique S.A. | Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
NZ579820A (en) | 2007-04-27 | 2011-01-28 | Purdue Pharma Lp | Therapeutic agents useful for treating pain |
PT2142529E (en) | 2007-04-27 | 2014-03-20 | Purdue Pharma Lp | Trpv1 antagonists and uses thereof |
FR2932482B1 (en) * | 2008-06-13 | 2010-10-08 | Sanofi Aventis | NOVEL (PHENYL-3,6-DIHYDRO-2H-PYRIDINYL) - (PIPERAZINYL PONTE) -1-ALKANONE DERIVATIVES AND THEIR USE AS P75 INHIBITORS |
FR2932481B1 (en) * | 2008-06-13 | 2010-10-08 | Sanofi Aventis | 4- {2-4-PHENYL-3,6-DIHYDRO-2H-PYRIDIN-1-YL] -2-OXO-ALKYL} -1-PIPERAZIN-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE. |
US8703962B2 (en) | 2008-10-24 | 2014-04-22 | Purdue Pharma L.P. | Monocyclic compounds and their use as TRPV1 ligands |
US8759362B2 (en) | 2008-10-24 | 2014-06-24 | Purdue Pharma L.P. | Bicycloheteroaryl compounds and their use as TRPV1 ligands |
FR2953839A1 (en) | 2009-12-14 | 2011-06-17 | Sanofi Aventis | NOVEL (HETEROCYCLE-PIPERIDINE CONDENSEE) - (PIPERAZINYL) -1ALCANONE OR (HETEROCYCLE-PYRROLIDINE CONDENSED) - (PIPERAZINYL) -1ALCANONE DERIVATIVES AND THEIR USE AS INHIBITORS OF P75 |
FR2953836B1 (en) | 2009-12-14 | 2012-03-16 | Sanofi Aventis | NOVEL DERIVATIVES (HETEROCYCLE-TETRAHYDRO-PYRIDINE) - (PIPERAZINYL) -1-ALKANONE AND (HETEROCYCLE-DIHYDRO-PYRROLIDINE) - (PIPERAZINYL) -1-ALKANONE AND THEIR USE AS INHIBITORS OF P75 |
EP2585446A4 (en) | 2010-06-22 | 2013-12-25 | Shionogi & Co | Compounds having trpv1 antagonistic activity and uses thereof |
SG195136A1 (en) | 2011-06-22 | 2013-12-30 | Purdue Pharma Lp | Trpv1 antagonists including dihydroxy substituent and uses thereof |
US9394293B2 (en) | 2011-08-10 | 2016-07-19 | Purdue Pharma L.P. | TRPV1 antagonists including dihydroxy substituent and uses thereof |
EP2606894A1 (en) | 2011-12-20 | 2013-06-26 | Sanofi | Novel therapeutic use of p75 receptor antagonists |
US9221796B2 (en) | 2014-01-09 | 2015-12-29 | Bristol-Myers Squibb Company | Selective NR2B antagonists |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
GB9221931D0 (en) * | 1992-10-17 | 1992-12-02 | Wyeth John & Brother Ltd | Piperazine derivatives |
FR2722788B1 (en) * | 1994-07-20 | 1996-10-04 | Pf Medicament | NOVEL PIPERAZIDES DERIVED FROM ARYL PIPERAZINE, PROCESSES FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
-
1996
- 1996-02-02 FR FR9601275A patent/FR2744448B1/en not_active Expired - Fee Related
-
1997
- 1997-01-31 AU AU16070/97A patent/AU1607097A/en not_active Abandoned
- 1997-01-31 EP EP97902419A patent/EP0886636A1/en not_active Withdrawn
- 1997-01-31 CA CA002244940A patent/CA2244940A1/en not_active Abandoned
- 1997-01-31 WO PCT/FR1997/000195 patent/WO1997028140A1/en not_active Application Discontinuation
- 1997-01-31 BR BR9707261A patent/BR9707261A/en not_active Application Discontinuation
- 1997-01-31 CN CN97192737A patent/CN1212690A/en active Pending
- 1997-01-31 JP JP9527373A patent/JP2000504004A/en active Pending
- 1997-01-31 NZ NZ331221A patent/NZ331221A/en unknown
-
1998
- 1998-08-03 MX MX9806246A patent/MX9806246A/en unknown
Also Published As
Publication number | Publication date |
---|---|
FR2744448B1 (en) | 1998-04-24 |
WO1997028140A1 (en) | 1997-08-07 |
JP2000504004A (en) | 2000-04-04 |
AU1607097A (en) | 1997-08-22 |
CN1212690A (en) | 1999-03-31 |
CA2244940A1 (en) | 1997-08-07 |
NZ331221A (en) | 2000-01-28 |
FR2744448A1 (en) | 1997-08-08 |
MX9806246A (en) | 1998-11-29 |
EP0886636A1 (en) | 1998-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9707261A (en) | Compound processes for preparing them and pharmaceutical products and compositions | |
ZA9510146B (en) | Novel perhydroisoindole derivatives processes for their preparation and pharmaceutical compositions comprising them | |
ITMI950529A0 (en) | PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION | |
EE9500064A (en) | Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions | |
IS4706A (en) | pharmaceutical compositions | |
NO20001409L (en) | Carboxamidothiazole derivatives, processes for their preparation and pharmaceutical compositions | |
IL119078A (en) | Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them | |
BR9707251A (en) | Process compounds for their preparation and pharmaceutical compositions | |
BR9602933A (en) | Compound processes for preparation of compost and pharmaceutical composition and compost | |
FI973279A0 (en) | Novel farnesyltransferase inhibitors, their preparation and pharmaceutical compositions containing them | |
IL127798A (en) | N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them | |
PT787745E (en) | PREPARATION OF INULIN PRODUCTS | |
ID18352A (en) | PHARMACEUTICAL COMPOSITIONS | |
EE9900112A (en) | 2-Cyanoiminoimidazole derivatives, process for their preparation, use and pharmaceutical compositions | |
IL110201A (en) | Pharmaceutical compositions comprising quinoline-3-carboxamide derivatives | |
IL118427A (en) | N-acyl-2 aryl cycloalkylmethylamine derivatives as melatonergics and pharmaceutical compositions comprising them | |
IL117397A (en) | Substituted naphthyl compounds and pharmaceutical compositions comprising them | |
EE9900260A (en) | Pharmaceutical compositions for freeze-drying | |
FI960316A0 (en) | Oxathiolanes, process for their preparation and pharmaceutical compositions containing them | |
EE03996B1 (en) | Pharmaceutical compositions, process for their preparation and use | |
BR9507768A (en) | Pharmaceutical composition | |
PT939083E (en) | PROCESS FOR PREPARATION AND ITS PHARMACEUTICAL COMPOSITIONS | |
PT941100E (en) | PHARMACEUTICAL COMPOSITIONS | |
ITMI942166A0 (en) | PHARMACEUTICAL COMPOSITIONS MIORELAXANTS | |
ITMI951417A0 (en) | PHARMACEUTICAL COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |